Literature DB >> 12584748

Health profiles in 5836 long-term cancer survivors.

Pamela N Schultz1, Martha L Beck, Charles Stava, Rena Vassilopoulou-Sellin.   

Abstract

Increasingly, prolonged survival follows the diagnosis of cancer. Cancer therapies result in complex and lasting health effects that create unique health-care needs for the survivors but are poorly understood (especially in survivors of adult cancers). Cancer survivors were asked to respond to a mailed health survey and provide medical and social information pertaining to their cancer experience. Information about demographics and perceived disease-related medical problems was analyzed. We analyzed the response of 5,836 survivors of adult cancers. Two-thirds of the responses came from women, and the response rate was 51% in both sexes. The mean interval since cancer diagnosis was 18.0 +/- 8.5 years. Younger survivors and men were more likely to report that cancer had affected their health. The health effect most commonly reported by survivors was arthritis/osteoporosis (26% of respondents). Survivors of Hodgkin's disease prominently reported thyroid and lung problems (33.8% of responders with the diagnosis). Prior diagnosis of lymphoma was associated with frequent mention of memory loss (14.7%). The passage of time decreased some perceived effects (memory loss) but increased others (arthritis/osteoporosis, cataracts). Compared with the general population, the incidence of several age- and gender-adjusted health conditions in cancer survivors is different. This group of cancer survivors reported generally good health but outlined multiple lasting medical problems. The health survey described represents 1 approach to the development of comprehensive information about the health needs of cancer survivors. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12584748     DOI: 10.1002/ijc.10981

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  49 in total

1.  Improving quality of life among latino cancer survivors: Design of a randomized trial of patient navigation.

Authors:  Amelie G Ramirez; Kipling J Gallion; Arely Perez; Edgar Munoz; Dorothy Long Parma; Patricia I Moreno; Frank J Penedo
Journal:  Contemp Clin Trials       Date:  2018-11-03       Impact factor: 2.226

Review 2.  Monitoring chemotherapy-induced cardiotoxicity: role of cardiac nuclear imaging.

Authors:  Gurusher Singh Panjrath; Diwakar Jain
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

Review 3.  Chemotherapy agents and hypertension: a focus on angiogenesis blockade.

Authors:  Manish Jain; Raymond R Townsend
Journal:  Curr Hypertens Rep       Date:  2007-08       Impact factor: 5.369

4.  Risk Factors for Cardiovascular Disease Among Thyroid Cancer Survivors: Findings From the Utah Cancer Survivors Study.

Authors:  Jihye Park; Brenna E Blackburn; Patricia A Ganz; Kerry Rowe; John Snyder; Yuan Wan; Vikrant Deshmukh; Michael Newman; Alison Fraser; Ken Smith; Kim Herget; Anne C Kirchhoff; Dev Abraham; Jaewhan Kim; Marcus Monroe; Mia Hashibe
Journal:  J Clin Endocrinol Metab       Date:  2018-07-01       Impact factor: 5.958

5.  A comparative analysis of the health and well-being of cancer survivors to the general population.

Authors:  Olinda Santin; Moyra Mills; Charlene Treanor; Michael Donnelly
Journal:  Support Care Cancer       Date:  2012-01-20       Impact factor: 3.603

6.  Health-related quality of life among long-term survivors of colorectal cancer: a population-based study.

Authors:  Agnès Caravati-Jouvenceaux; Guy Launoy; Delphine Klein; Michel Henry-Amar; Edwige Abeilard; Arlette Danzon; Astrid Pozet; Michel Velten; Mariette Mercier
Journal:  Oncologist       Date:  2011-10-10

Review 7.  Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer.

Authors:  Wendy Demark-Wahnefried; Noreen M Aziz; Julia H Rowland; Bernardine M Pinto
Journal:  J Clin Oncol       Date:  2005-07-25       Impact factor: 44.544

8.  Long-term breast cancer survivors' symptoms and morbidity: differences by sexual orientation?

Authors:  Ulrike Boehmer; Mark Glickman; Michael Winter; Melissa A Clark
Journal:  J Cancer Surviv       Date:  2013-01-18       Impact factor: 4.442

9.  IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice.

Authors:  Michelle C Janelsins; Joseph A Roscoe; Michel J Berg; Bryan D Thompson; Mark J Gallagher; Gary R Morrow; Charles E Heckler; Pascal Jean-Pierre; Lisa A Opanashuk; Robert A Gross
Journal:  Cancer Invest       Date:  2010-06       Impact factor: 2.176

10.  Gender, race, BMI, and social support in relation to the health-related quality of life of cancer survivors: a report from the American Cancer Society's Study of Cancer Survivors II (SCS-II).

Authors:  Ruth P Westby; Carla J Berg; Corinne Leach
Journal:  Qual Life Res       Date:  2015-08-20       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.